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individual patient’s needs, and to re-
place/upsize them as needed.
We have several practical tips for stent-
ing of type 3 and 4 bronchial stenoses:
1. We have found that stenting of the
subsegmental airways does not
benefit the patient. Thus, we limit
our stenting to the bronchial and
segmental airways.
2. We calibrate the size of stent to be
placed based on the size of the rigid
bronchoscope that we are able to in-
sert in the portion of bronchus af-
fected. For example, if we are able
to cannulate the affected bronchus
with a 10-mm rigid bronchoscope,
we would size the proximal portion
of the stent to 10 to 12 mm.
3. For difficult and long stenoses, we
often dilate the bronchus/segment
and insert as large a stent as possi-
ble. In 2 to 3 months, we remove
the stent and replace it with a larger
diameter stent. This can be done
sequentially to maximally dilate
the affected area.
4. For distal left-sided problems, we
routinely place the stent over the bi-
furcation of the upper and lower
lobes and cut a small circular seg-
ment out of the stent using a 6-
mm dermal punch (Acuderm, Fort
Lauderdale, FL). This stent con-
touring maintains the integrity of
the stent while allowing for ventila-
tion of the upper lobe, which would
otherwise be obstructed.
5. For distal right-sided problems, we
use step-down stents of various
configurations (Hood Silastic 2-
Step Stents with Posts and Mesh:
Hood Laboratories). A step-down
stent is one in which the proximal
diameter is larger than the distal di-
ameter, with tapering of the stent
diameter in between. Step-down
stents allow coverage down to the
level of the superior segment of
the lower lobe and right middle
lobe, while maintaining patency
and coverage of the anastomosis
and proximal mainstem bronchus.
We usually cut a 6-mm dermal
punch hole in the stent for the right
upper lobe to allow ventilation to
this lobe. The right upper lobe ori-
fice is often variable in its position,
so we have not found stents with
premade orifices effective for use.
6. While inserting Silastic stents, we
have found that it is important to
place the hole for a lobar orifice
corresponding to the print on the
metallic applicator (Dumon-Harrell
applicator: Bryan Corporation).
This configuration allows for easy
rotation of the stent (clockwise for
right bronchial stents, counterclock-
wise for left bronchial stents) into
the appropriate position as it is
deployed. After stent deployment,
we then often put a flexible bron-
choscope through the rigid bron-
choscope into the stent while using
rigid forceps to manipulate the
hole into its most optimal position.
Our experience has been that bron-
choscopic surveillance and sequential
‘‘up-size’’ stenting for distal long-seg-
ment stenoses is an effective way to
permanently increase luminal diame-
ter over a long length of airway.
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To the Editor:
We read with interest the article by
Stamou and colleagues,1 who showed
that a quality improvement program de-al of Thoracic and Cardiovascular Surcreased mortality after cardiac surgery
in a large cohort, using a risk-adjusted
methodology. Most importantly, out-
comes improved mostly due to fewer
cardiac-related deaths. Moreover, there
was a lower relative decline in mortality
among patients with diabetes than
among those without diabetes, indicat-
ing the influence of patient individual
factors on outcomes. Finally, they con-
clude that future quality improvement
programs should focus on high-risk
patients, which they misclassified as
those with diabetes. It would be more
appropriate if the authors provide in-
formation about severity scores widely
available in the literature instead.
Quality improvement programs fol-
low institutional or regional/national
initiatives. Although the latter are im-
portant to monitor and foster improve-
ment of outcomes, the former are
fundamental to develop a sustained
and cost-effective system locally. Be-
cause processes of care vary widely
among cardiac surgery programs,
there are no ‘‘recipes’’ that can be uni-
versally applied, due to system-based
particularities. Core components of
the quality improvement program de-
scribed by Stamou and colleagues1
are important, but such programs
should be presented in a problem-
based approach. It would be interest-
ing to know the problems responsible
for the initial unfavorable outcomes.
That would potentially guide other
cardiac surgery centers in implement-
ing similar programs. Moreover, infor-
mation about the financial impact
(investment and savings) of those pro-
grams is crucial, particularly in times
of world economic crisis.
In Brazil, results of cardiac sur-
gery are not as good as in developed
countries.2 Reasons are multiple, but
certainly include different patient
profiles, social problems, limited re-
sources, and poorly developed hospital
operating systems and integrated patient
care. In our center, multimodal strate-
gies were added, aiming for team build-
ing and a more organized and integrated
hospital system. No substantial resourcegery c Volume 138, Number 1 253
majormorbidity (nosocomial infections,
acute renal failure, hemorrhage, reop-
erations, etc) through elimination of
variation while reliably applying the
best available evidence as well as best
practices. Regarding the comment
about severity scores, The Society of
Thoracic Surgeons (STS)–National
Cardiac Database allowed us to com-
pare our performance to national aver-
ages and guided our efforts. STS
developed definitions for key data ele-
ments, providing a common language
and standards. STS also developed
risk-adjusted mortality and morbidity
algorithms to provide benchmark mea-
sures that helped in the construction of
our standard operating procedure. STS
risk scores were routinely recorded in
our QIP efforts and used to calculate
expected mortality and compare it
with the national average. However,
reporting risk scores was beyond our
focus. The most important finding of
our article was that by building a QIP,
a measurable and significant decrease
in mortality can be accomplished, and
on that regard, our article was among
the first to report such a finding.
We tend to disagree with Dr Atik’s
comments that QIPs follow institutional
or regional/national initiatives. A QIP
can follow both national/regional initia-
tives and at the same time be tailored to
each institution’s needs and particulari-
ties. Our QIP was structured based on
STS guidelines and best evidence prac-
tices but was also adjusted to our institu-
tion’s particular goals.
An important finding of our work is
that a QIP did not improve dramati-
cally the outcomes on diabetic patients,
as previously reported.3 Similarly, Van
Den Berghe and colleagues3 demon-
strated that with their intensive insulin
nary artery disease) frequently encoun-
tered in diabetic patients, the higher
risk for wound infection, and the
higher risk of mortality compared
with nondiabetic patients as well as
the resistance of diabetic patients to
improve with QIP initiatives provided
the rationale for our proposition.
We tend to agree with Dr Atik’s
statement that ‘‘because processes of
care vary widely among cardiac sur-
gery programs, there are no ‘recipes’
that can be universally applied, due
to system-based particularities.’’
However, common denominators
of successful QIP efforts include
a dedicated multidisciplinary team
with common goals, a systems-based
approach, accurate communication,
adherence to strict protocols, and mon-
itoring compliance. In this respect,
some universally applied rules may ap-
ply. Regarding the reasons for the
change in outcomes, we believe there
is a multifactorial etiology: mainly
the absence of a dedicated multidisci-
plinary team, the lack of a monitoring
tool to measure compliance to the pro-
tocols, and individualized rather than
a team approach to clinical problem
solving during the initial period before
development of QIP. In contradistinc-
tion, our systems-based approach,
standardization, team building, consis-
tent and accurate communication, and
active management of change and
quality accounted for a recent decline
of 48% in mortality.
The financial impact (investment
and savings) of QIP is indeed crucial.
We previously demonstrated that by
implementing QIP, a significant in-
crease in the early extubation rates,
a decrease in intensive care unit stay,
and resource utilization can be accom-
Letters to the Editorinvestment was necessary. The impact
of those strategies was analyzed by mul-
tivariate logistic regression (unpub-
lished data). Risk-adjusted hospital
mortality declined (from 11.5% to
3.6%, P ¼ .003) after these strategies
were implemented. Survival benefit
was particularly evident in high-risk pa-
tients (Euroscore>7), in which opera-
tions performed prior to the quality
program were independently associated
with greater mortality (odds ratio¼ 4.8;
95% confidence interval 1.6–17.4; P¼
.005). There was no difference in low-
risk patients (Euroscore<6). Therefore,
multimodal strategies in our center re-
markably improved the outcomes of
high-risk cardiac surgery patients, as op-
posed to low-risk patients, which are
probably less dependent on the system.
Quality in cardiac surgery is ulti-
mately a surgeon’s responsibility and
should be part of the training of young
surgeons. We would like to congratu-
late Dr Stamou and colleagues on their
excellent work on an extremely impor-
tant subject.
Fernando A. Atik, MD
Instituto de Cardiologia do Distrito
Federal
Fundac¸a˜o Universita´ria de
Cardiologia
Brasilia, Brazil
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We appreciate Dr Atik’s kind com-
ments and thoughtful questions. Addi-
tionally, his efforts are to be recognized
and commended. Our quality improve-
ment program (QIP)1,2 was developed
to address opportunities to reduce
mortality and mitigate the risk of
therapy protocol, they were able to re-
duce mortality of all medical/surgical
intensive care unit patients, except
those with a prior history of diabetes.
Our investigation corroborated this
finding that diabetics are a high-risk
subset of patients on which future
QIP efforts should focus. The presence
of small target vessels (diffuse coro-
plished.2 We are in the process of ana-
lyzing the specific financial impact of
our QIP, and this will be the focus of
a future publication. We believe that
by using a unique database linking
clinical and financial outcomes
through a focus on quality, cost con-
tainment in cardiac surgical care can
be achieved by identifying and
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